Anemia News and Research

RSS
Anemia is a decrease in normal number of red blood cells (RBCs) or less than the normal quantity of hemoglobin in the blood. However, it can include decreased oxygen-binding ability of each hemoglobin molecule due to deformity or lack in numerical development as in some other types of hemoglobin deficiency. The three main classes of anemia include excessive blood loss (acutely such as a hemorrhage or chronically through low-volume loss), excessive blood cell destruction (hemolysis) or deficient red blood cell production (ineffective hematopoiesis). Anemia is the most common disorder of the blood. There are several kinds of anemia, produced by a variety of underlying causes. Anemia can be classified in a variety of ways, based on the morphology of RBCs, underlying etiologic mechanisms, and discernible clinical spectra, to mention a few.
Celgene's ISTODAX sNDA granted FDA Priority Review classification for progressive/relapsed PTCL

Celgene's ISTODAX sNDA granted FDA Priority Review classification for progressive/relapsed PTCL

Alexion joins EURORDIS, NORD and medical communities to observe Rare Disease Day 2011

Alexion joins EURORDIS, NORD and medical communities to observe Rare Disease Day 2011

Scripps Health offers genetic testing to patients with Hepatitis C

Scripps Health offers genetic testing to patients with Hepatitis C

AMAG fourth quarter total revenues increase to $17.2 million

AMAG fourth quarter total revenues increase to $17.2 million

The Lancet journal publishes XGEVA Phase 3 study results against prostate cancer, bone metastases

The Lancet journal publishes XGEVA Phase 3 study results against prostate cancer, bone metastases

Study: Newborn screening for hemoglobin H disease can reduce mortality rate

Study: Newborn screening for hemoglobin H disease can reduce mortality rate

First patient enrolled in TXA127 Phase 2 clinical study to stimulate engraftment following transplant

First patient enrolled in TXA127 Phase 2 clinical study to stimulate engraftment following transplant

Positive preliminary data from Fate Therapeutics FT1050 Phase 1b trial in patients with life-threatening conditions

Positive preliminary data from Fate Therapeutics FT1050 Phase 1b trial in patients with life-threatening conditions

Positive results from TMC435 phase 2b PILLAR study in treatment-naive patients with HCV

Positive results from TMC435 phase 2b PILLAR study in treatment-naive patients with HCV

Genzyme reports 3-year follow-up data from eliglustat tartrate Phase 2 trial for Gaucher disease

Genzyme reports 3-year follow-up data from eliglustat tartrate Phase 2 trial for Gaucher disease

2 bills to expand mental health coverage introduced

2 bills to expand mental health coverage introduced

Positive interim data from cabozantinib Phase 2 metastatic castration-resistant prostate cancer trial

Positive interim data from cabozantinib Phase 2 metastatic castration-resistant prostate cancer trial

Metallic copper surfaces kill bacteria on contact

Metallic copper surfaces kill bacteria on contact

Spirulina Pacifica supplement may improve immune function, anemia in senior citizens

Spirulina Pacifica supplement may improve immune function, anemia in senior citizens

Viewpoints: Expediting SCOTUS health law review; birth control funding; budget cutting and the stock market

Viewpoints: Expediting SCOTUS health law review; birth control funding; budget cutting and the stock market

State court jury rules in favor of Merck in FOSAMAX trial

State court jury rules in favor of Merck in FOSAMAX trial

SynthRx to become wholly-owned subsidiary of ADVENTRX

SynthRx to become wholly-owned subsidiary of ADVENTRX

Silent strokes can cause long-term cognitive, learning deficits in children with sickle cell disease

Silent strokes can cause long-term cognitive, learning deficits in children with sickle cell disease

Afinitor plus BSC doubles progression-free survival in patients with advanced pancreatic neuroendocrine tumors

Afinitor plus BSC doubles progression-free survival in patients with advanced pancreatic neuroendocrine tumors

Mobily introduces first mobile medical imaging service

Mobily introduces first mobile medical imaging service

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.